Development of Covalent Ligand-Receptor Pairs to Study the Binding Properties of Nonpeptidic Neurotensin Receptor 1 Antagonists

ACS Chemical Biology

Volumn 11, Issue 4, 2016, Pages 869-875

  Kling, Ralf C ^a   Plomer, Manuel ^a   Lang, Christopher ^a   Banerjee, Ashutosh ^a   Hübner, Harald ^a   Gmeiner, Peter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; CYSTEINE; DISULFIDE; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 1; NEUROTENSIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; LIGAND; PROTEIN BINDING;

ARTICLE; CONTROLLED STUDY; COVALENT BOND; CRYSTAL STRUCTURE; DRUG BINDING; DRUG DESIGN; ENZYME ENGINEERING; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN INTERACTION; ANTAGONISTS AND INHIBITORS; HUMAN;

HUMANS; LIGANDS; PROTEIN BINDING; RECEPTORS, NEUROTENSIN;

EID: 84966440329     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/acschembio.5b00965     Document Type: Article

References (33)

1. Wise, A., Gearing, K., and Rees, S. (2002) Target validation of G-protein coupled receptors Drug Discovery Today 7, 235-246 10.1016/S1359-6446(01)02131-6
2. Kobilka, B. (2013) The structural basis of g-protein-coupled receptor signaling (nobel lecture) Angew. Chem., Int. Ed. 52, 6380-6388 10.1002/anie.201302116
3. Ghosh, E., Kumari, P., Jaiman, D., and Shukla, A. K. (2015) Methodological advances: the unsung heroes of the GPCR structural revolution Nat. Rev. Mol. Cell Biol. 16, 69-81 10.1038/nrm3933
4. Shonberg, J., Kling, R. C., Gmeiner, P., and Löber, S. (2015) GPCR crystal structures: Medicinal chemistry in the pocket Bioorg. Med. Chem. 23, 3880-3906 10.1016/j.bmc.2014.12.034
5. White, J. F., Noinaj, N., Shibata, Y., Love, J., Kloss, B., Xu, F., Gvozdenovic-Jeremic, J., Shah, P., Shiloach, J., Tate, C. G., and Grisshammer, R. (2012) Structure of the agonist-bound neurotensin receptor Nature 490, 508-513 10.1038/nature11558
6. Egloff, P., Hillenbrand, M., Klenk, C., Batyuk, A., Heine, P., Balada, S., Schlinkmann, K. M., Scott, D. J., Schutz, M., and Pluckthun, A. (2014) Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 111, 655-662 10.1073/pnas.1317903111
7. Krumm, B. E., White, J. F., Shah, P., and Grisshammer, R. (2015) Structural prerequisites for G-protein activation by the neurotensin receptor Nat. Commun. 6, 7895 10.1038/ncomms8895
8. Kinkead, B., Binder, E. B., and Nemeroff, C. B. (1999) Does neurotensin mediate the effects of antipsychotic drugs? Biol. Psychiatry 46, 340-351 10.1016/S0006-3223(99)00070-0
9. Binder, E. B., Kinkead, B., Owens, M. J., and Nemeroff, C. B. (2001) Neurotensin and dopamine interactions Pharmacol Rev. 53, 453-486
10. Koschatzky, S., Tschammer, N., and Gmeiner, P. (2011) Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics ACS Chem. Neurosci. 2, 308-316 10.1021/cn200020y
11. Gully, D., Canton, M., Boigegrain, R., Jeanjean, F., Molimard, J. C., Poncelet, M., Gueudet, C., Heaulme, M., Leyris, R., and Brouard, A. et al. 1993, Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor Proc. Natl. Acad. Sci. U. S. A. 90, 65-69 10.1073/pnas.90.1.65
12. Lang, C., Maschauer, S., Hubner, H., Gmeiner, P., and Prante, O. (2013) Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors J. Med. Chem. 56, 9361-9365 10.1021/jm401491e
13. Maschauer, S., Ruckdeschel, T., Tripal, P., Haubner, R., Einsiedel, J., Hubner, H., Gmeiner, P., Kuwert, T., and Prante, O. (2014) In vivo monitoring of the antiangiogenic effect of neurotensin receptor-mediated radiotherapy by small-animal positron emission tomography: a pilot study Pharmaceuticals 7, 464-481 10.3390/ph7040464
14. Leach, A. R., Shoichet, B. K., and Peishoff, C. E. (2006) Prediction of protein-ligand interactions. Docking and scoring: successes and gaps J. Med. Chem. 49, 5851-5855 10.1021/jm060999m
15. Shoichet, B. K. and Kobilka, B. K. (2012) Structure-based drug screening for G-protein-coupled receptors Trends Pharmacol. Sci. 33, 268-272 10.1016/j.tips.2012.03.007
16. Dror, R. O., Pan, A. C., Arlow, D. H., Borhani, D. W., Maragakis, P., Shan, Y., Xu, H., and Shaw, D. E. (2011) Pathway and mechanism of drug binding to G-protein-coupled receptors Proc. Natl. Acad. Sci. U. S. A. 108, 13118-13123 10.1073/pnas.1104614108
17. Dror, R. O., Green, H. F., Valant, C., Borhani, D. W., Valcourt, J. R., Pan, A. C., Arlow, D. H., Canals, M., Lane, J. R., Rahmani, R., Baell, J. B., Sexton, P. M., Christopoulos, A., and Shaw, D. E. (2013) Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs Nature 503, 295-299 10.1038/nature12595
18. Erlanson, D. A., Wells, J. A., and Braisted, A. C. (2004) Tethering: fragment-based drug discovery Annu. Rev. Biophys. Biomol. Struct. 33, 199-223 10.1146/annurev.biophys.33.110502.140409
19. Buck, E. and Wells, J. A. (2005) Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor Proc. Natl. Acad. Sci. U. S. A. 102, 2719-2724 10.1073/pnas.0500016102
20. Weichert, D. and Gmeiner, P. (2015) Covalent Molecular Probes for Class A G Protein-Coupled Receptors: Advances and Applications ACS Chem. Biol. 10, 1376-1386 10.1021/acschembio.5b00070
21. Rosenbaum, D. M., Zhang, C., Lyons, J. A., Holl, R., Aragao, D., Arlow, D. H., Rasmussen, S. G., Choi, H. J., Devree, B. T., Sunahara, R. K., Chae, P. S., Gellman, S. H., Dror, R. O., Shaw, D. E., Weis, W. I., Caffrey, M., Gmeiner, P., and Kobilka, B. K. (2011) Structure and function of an irreversible agonist-beta(2) adrenoceptor complex Nature 469, 236-240 10.1038/nature09665
22. Weichert, D., Kruse, A. C., Manglik, A., Hiller, C., Zhang, C., Hubner, H., Kobilka, B. K., and Gmeiner, P. (2014) Covalent agonists for studying G protein-coupled receptor activation Proc. Natl. Acad. Sci. U. S. A. 111, 10744-10748 10.1073/pnas.1410415111
23. Harterich, S., Koschatzky, S., Einsiedel, J., and Gmeiner, P. (2008) Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1 Bioorg. Med. Chem. 16, 9359-9368 10.1016/j.bmc.2008.08.051
24. Lang, C. and Gmeiner, P. (2013) Efficient Synthesis of Heterocyclic Neurotensin Receptor Ligands by Microwave-Assisted Aminocarbonylation Synthesis 45, 2474-2480 10.1055/s-0033-1338497
25. Khazaei, A., Zolfigol, M. A., and Rostami, A. (2004) 1,3-dibromo-5,5-dimethylhydantoin [DBDMH] as an efficient and selective agent for the oxidation of thiols to disulfides in solution or under solvent-free conditions Synthesis 2959-2961 10.1055/s-2004-834919
26. Zhang, S. Y. and Zhao, Y. (2010) Rapid Release of Entrapped Contents from Multi-Functionalizable, Surface Cross-Linked Micelles upon Different Stimulation J. Am. Chem. Soc. 132, 10642-10644 10.1021/ja103391k
27. Einsiedel, J., Held, C., Hervet, M., Plomer, M., Tschammer, N., Hubner, H., and Gmeiner, P. (2011) Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics J. Med. Chem. 54, 2915-2923 10.1021/jm200006c
28. Labbe-Jullie, C., Barroso, S., Nicolas-Eteve, D., Reversat, J. L., Botto, J. M., Mazella, J., Bernassau, J. M., and Kitabgi, P. (1998) Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist J. Biol. Chem. 273, 16351-16357 10.1074/jbc.273.26.16351
29. Schaab, C., Kling, R. C., Einsiedel, J., Hübner, H., Clark, T., Seebach, D., and Gmeiner, P. (2014) Structure-Based Evolution of Subtype-Selective Neurotensin Receptor Ligands ChemistryOpen 3, 206-218 10.1002/open.201402031
30. Richard, F., Barroso, S., Nicolas-Etheve, D., Kitabgi, P., and Labbe-Jullie, C. (2001) Impaired G protein coupling of the neurotensin receptor 1 by mutations in extracellular loop 3 Eur. J. Pharmacol. 433, 63-71 10.1016/S0014-2999(01)01496-0
31. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., and Ferrin, T. E. (2004) UCSF Chimera-a visualization system for exploratory research and analysis J. Comput. Chem. 25, 1605-1612 10.1002/jcc.20084
32. Laskowski, R. A. and Swindells, M. B. (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery J. Chem. Inf. Model. 51, 2778-2786 10.1021/ci200227u
33. Lückmann, M., Holst, B., Schwartz, T. W., and Frimurer, T. M. (2016) In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide Agonist Mol. Inf. 35, 19 10.1002/minf.201500080